Press Releases | BioNTech

13 November 2024

BioNTech to Acquire Biotheus to Boost Oncology Strategy

Read on

4 November 2024

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update

Read on

31 October 2024

BioNTech to Host Innovation Series R&D Day on November 14, 2024

Read on

21 October 2024

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024

Read on

1 October 2024

BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day

Read on

20 September 2024

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Read on

17 September 2024

BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024

Read on

5 September 2024

BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024

Read on

22 August 2024

Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine

Read on

19 August 2024

Lift of Partial Clinical Hold for BNT326/YL202

Read on

The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. BioNTech disavows any obligation to update the information contained in such press releases after the date of their issuance.